Malaysia is moving to capture a larger share of the Bangladeshi medical travel market as visa-related disruptions in traditional destinations like India prompt patients to look further afield. The Malaysia Healthcare Travel Council (MHTC) has intensified its engagement in Dhaka, leveraging the momentum of the Malaysia Year of Medical Tourism 2026 (MYMT 2026).
The upcoming Malaysia Healthcare Week in Dhaka is a tactical effort to integrate Malaysia’s medical ecosystem—specialising in cardiology, oncology, and organ transplantation—directly into the Bangladeshi healthcare referral network.
The Strategic ‘Visa Gap’
For decades, proximity made India the default choice for Bangladeshi patients. However, recent and persistent visa restrictions and diplomatic frictions in early 2026 have created a “treatment corridor” vacuum. Malaysia is stepping in with a compelling value proposition:
- Structural Growth: The sector generated RM3.34 billion in revenue in 2025, serving 1.84 million international travellers.
- Connectivity: Multiple daily direct flights between Dhaka and Kuala Lumpur (including Malaysia Airlines and AirAsia) ensure seamless patient mobility.
- Specialised Dominance: By showcasing flagship institutions like IJN and Subang Jaya Medical Centre, MHTC is targeting high-value, complex cases.
Editor’s Take: The ‘Hospitality’ Moat
Under CEO Suriaghandi Suppiah, MHTC is playing a sophisticated game of “Cultural Competency.” While regional competitors offer similar technology, Malaysia’s “Healing Meets Hospitality” positioning specifically targets the sensibilities of the Bangladeshi market. By aligning clinical excellence with a familiar halal-friendly environment and competitive pricing, Malaysia is not just seeking patients; it is building a long-term, cross-border partnership.